Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Galena Biopharma Inc    GALE   US3632561086

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/11/2014 04/14/2014 04/15/2014 04/16/2014 04/17/2014 Date
2.06(c) 1.88(c) 1.74(c) 1.86(c) 1.8(c) Last
3 160 640 5 849 187 7 286 157 3 297 219 2 606 357 Volume
-4.63% -8.74% -7.45% +6.90% -3.23% Change
More quotes
Company
Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. It currently develops peptide antigenbased off the shelf cancer immunotherapies for... 
Sector
Biotechnology
Calendar
05/19Earnings Release
Surperformance© rating of Galena Biopharma Inc
Trading Rating : Investor Rating :
More about the company
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 13,5 M
EBIT 2014 -40,9 M
Net income 2014 -39,9 M
Debt 2014 -
Yield 2014 -
Sales 2015 23,9 M
EBIT 2015 -31,3 M
Net income 2015 -36,7 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 15,2x
Capi. / Sales 2015 8,59x
Capitalization 205 M
More Financials
Latest news on GALENA BIOPHARMA INC
04/11 GALENA BIOPHARMA : Lieff Cabraser Reminds Galena Biopharma, Inc. Investors of Up..
04/10 GALENA BIOPHARMA : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors o..
04/09 GALENA BIOPHARMA : SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have..
04/03 GALENA BIOPHARMA : INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investor..
04/03 GALENA BIOPHARMA : to Present at the 13th Annual Needham Healthcare Conference
03/31 GALENA BIOPHARMA : Hagens Berman Reminds Galena Biopharma, Inc. Investors of May..
03/28 GALENA BIOPHARMA : Cohen Milstein Sellers & Toll PLLC : Announces the Investigat..
03/26 GALENA BIOPHARMA : The Shuman Law Firm Investigates Galena Biopharma, Inc.
03/26 GALENA BIOPHARMA : Hagens Berman Investigating Galena Biopharma and CytRx Corpor..
03/21 GALENA BIOPHARMA : Lieff Cabraser Announces Class Action Litigation Against Gale..
03/20 SYNTHESIS ENERGY SYSTEMS, (NASDAQ : SYMX), Global Geophysical Services, (NYSE:GG..
03/20 GALENA BIOPHARMA : INVESTOR ALERT: Class Action Lawsuit against Galena Biopharma..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
Galena Biopharma Inc : Income Statement Evolution
More Financials
EPS Revisions
Galena Biopharma Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF